Line 34: |
Line 34: |
| ==Additional Information== | | ==Additional Information== |
| | | |
− | 1. ''ANKRD26 (OMIM: 610855)'' has been associated with thrombocytopenia 2 (OMIM: 188000, <nowiki>https://www.omim.org/entry/188000</nowiki>).
| + | * ''ANKRD26 (OMIM: 610855)'' has been associated with thrombocytopenia 2 (OMIM: 188000, <nowiki>https://www.omim.org/entry/188000</nowiki>). |
− | | + | * ''CEBPA (OMIM: 116897)'' has been associated with acute myeloid leukemia (OMIM: 601626, <nowiki>https://www.omim.org/entry/601626</nowiki>). |
− | 2. ''CEBPA (OMIM: 116897)'' has been associated with acute myeloid leukemia (OMIM: 601626, <nowiki>https://www.omim.org/entry/601626</nowiki>).
| + | * ''DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>). |
− | | + | * ''ETV6'' ''(OMIM: 600618)'' has been associated with thrombocytopenia 5 (OMIM: 616216, <nowiki>https://www.omim.org/entry/616216</nowiki>). |
− | ''3. DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>). | + | * ''GATA2 (OMIM: 137295)'' has been associated with susceptibility to acute myeloid leukemia (OMIM: 601626, <nowiki>https://www.omim.org/entry/601626</nowiki>). |
− | | + | * ''RUNX1'' ''(OMIM: 151385)'' has been associated with acute myeloid leukemia (OMIM: 601626) and familial platelet disorder with associated myeloid malignancy (OMIM: 601399, <nowiki>https://www.omim.org/entry/601399</nowiki>). |
− | ''4. ETV6'' ''(OMIM: 600618)'' has been associated with thrombocytopenia 5 (OMIM: 616216, <nowiki>https://www.omim.org/entry/616216</nowiki>). | + | * ''DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>). |
− | | + | * ''SAMD9'' ''(OMIM: 610456)'' has been associated with Myelodysplasia, Infection, Restriction of growth, Adrenal hypoplasia, Genital phenotypes, and Enteropathy (MIRAGE syndrome, OMIM: 617053, <nowiki>https://www.omim.org/entry/617053</nowiki>). |
− | ''5. GATA2 (OMIM: 137295)'' has been associated with susceptibility to acute myeloid leukemia (OMIM: 601626, <nowiki>https://www.omim.org/entry/601626</nowiki>). | + | * ''SAMD9L'' ''(OMIM: 611170)'' has been associated with ataxia-pancytopenia syndrome, or myelocerebellar disorder, ataxia-pancytopenia syndrome (OMIM: 159550, <nowiki>https://www.omim.org/entry/159550</nowiki>). |
− | | + | * ''SRP72'' ''(OMIM: 602122)'' has been associated with bone marrow failure syndrome 1 (OMIM: 614675, <nowiki>https://www.omim.org/entry/614675</nowiki>). |
− | ''6. RUNX1'' ''(OMIM: 151385)'' has been associated with acute myeloid leukemia (OMIM: 601626) and familial platelet disorder with associated myeloid malignancy (OMIM: 601399, <nowiki>https://www.omim.org/entry/601399</nowiki>). | + | * ''TP53'' ''(OMIM: 191170)'' has been associated with Li-Fraumeni syndrome (OMIM: 151623, <nowiki>https://www.omim.org/entry/151623</nowiki>). |
− | | + | * ''BLM'' ''(OMIM: 604610)'' has been associated with Bloom syndrome (OMIM: 210900, <nowiki>https://www.omim.org/entry/210900</nowiki>). |
− | ''7. DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>). | + | * Constitutional mismatch repair deficiency (OMIM: 276300, <nowiki>https://www.omim.org/entry/276300</nowiki>) |
− | | + | * Neurofibromatosis type I (NF1, OMIM: 162200, <nowiki>https://www.omim.org/entry/162200</nowiki>) |
− | ''8. SAMD9'' ''(OMIM: 610456)'' has been associated with Myelodysplasia, Infection, Restriction of growth, Adrenal hypoplasia, Genital phenotypes, and Enteropathy (MIRAGE syndrome, OMIM: 617053, <nowiki>https://www.omim.org/entry/617053</nowiki>). | + | * Nijmegen breakage syndrome (NBS, OMIM: 251260, <nowiki>https://www.omim.org/entry/251260</nowiki>) |
− | | + | * Noonan syndrome (please see Genetic heterogeneity of Noonan syndrome at <nowiki>https://www.omim.org/entry/163950</nowiki> |
− | ''9. SAMD9L'' ''(OMIM: 611170)'' has been associated with ataxia-pancytopenia syndrome, or myelocerebellar disorder, ataxia-pancytopenia syndrome (OMIM: 159550, <nowiki>https://www.omim.org/entry/159550</nowiki>). | + | * Fanconi anemia (FA, please see Genetic heterogeneity of Fanconi anemia at <nowiki>https://www.omim.org/entry/227650</nowiki>), |
− | | + | * Dyskeratosis congenital (DC, please see Genetic heterogeneity of dyskeratosis congenital at <nowiki>https://www.omim.org/entry/127550</nowiki>). |
− | ''10. SRP72'' ''(OMIM: 602122)'' has been associated with bone marrow failure syndrome 1 (OMIM: 614675, <nowiki>https://www.omim.org/entry/614675</nowiki>). | + | * Severe congenital neutropenia (SCN, please see Genetic heterogeneity of severe congenital neutropenia at <nowiki>https://www.omim.org/entry/202700</nowiki>) |
− | | + | * Shwachman-Diamond syndrome 1 (SDS1, OMIM: 260400, <nowiki>https://www.omim.org/entry/260400</nowiki>) and Shwachman-Diamond syndrome 2 (SDS2, OMIM: 617941, <nowiki>https://www.omim.org/entry/617941</nowiki>) |
− | ''11. TP53'' ''(OMIM: 191170)'' has been associated with Li-Fraumeni syndrome (OMIM: 151623, <nowiki>https://www.omim.org/entry/151623</nowiki>). | + | * Diamond Blackfan anemia (DBA, please see Genetic heterogeneity of Diamond Blackfan anemia at <nowiki>https://www.omim.org/entry/105650</nowiki>). |
− | | |
− | ''12. BLM'' ''(OMIM: 604610)'' has been associated with Bloom syndrome (OMIM: 210900, <nowiki>https://www.omim.org/entry/210900</nowiki>). | |
− | | |
− | 13. Constitutional mismatch repair deficiency (OMIM: 276300, <nowiki>https://www.omim.org/entry/276300</nowiki>)
| |
− | | |
− | 14. Neurofibromatosis type I (NF1, OMIM: 162200, <nowiki>https://www.omim.org/entry/162200</nowiki>)
| |
− | | |
− | 15. Nijmegen breakage syndrome (NBS, OMIM: 251260, <nowiki>https://www.omim.org/entry/251260</nowiki>)
| |
− | | |
− | 16. Noonan syndrome (please see Genetic heterogeneity of Noonan syndrome at <nowiki>https://www.omim.org/entry/163950</nowiki>
| |
− | | |
− | 17. Fanconi anemia (FA, please see Genetic heterogeneity of Fanconi anemia at <nowiki>https://www.omim.org/entry/227650</nowiki>),
| |
− | | |
− | 18. Dyskeratosis congenital (DC, please see Genetic heterogeneity of dyskeratosis congenital at <nowiki>https://www.omim.org/entry/127550</nowiki>).
| |
− | | |
− | 19. Severe congenital neutropenia (SCN, please see Genetic heterogeneity of severe congenital neutropenia at <nowiki>https://www.omim.org/entry/202700</nowiki>)
| |
− | | |
− | 20. Shwachman-Diamond syndrome 1 (SDS1, OMIM: 260400, <nowiki>https://www.omim.org/entry/260400</nowiki>) and Shwachman-Diamond syndrome 2 (SDS2, OMIM: 617941, <nowiki>https://www.omim.org/entry/617941</nowiki>)
| |
− | | |
− | 21. Diamond Blackfan anemia (DBA, please see Genetic heterogeneity of Diamond Blackfan anemia at <nowiki>https://www.omim.org/entry/105650</nowiki>).
| |
| | | |
| ==References== | | ==References== |